PRE 14A

PRELIMINARY PROXY

Company: Coeptis Therapeutics Holdings, Inc.
Filed: November 4, 2024
Period of Report: November 4, 2024
Accession Number: 0001683168-24-007588

View Document ↗ View on SEC.gov ↗